Select Medical Forecasts Q4 EPS of $0.23 and 3.7% Revenue Growth
Select Medical is scheduled to report Q4 2025 results on February 19, with earnings expected at $0.23 per share and revenues at $1.36 billion, reflecting year-over-year increases of 27.8% and 3.7% respectively. Full-year revenues are projected at $5.42 billion (down 18.2%) while EPS is seen rising 30.9% to $1.23.
1. Q4 Earnings and Revenue Estimates
Select Medical is set to announce Q4 2025 results on February 19, with estimates at $0.23 EPS and $1.36 billion in revenue, marking 27.8% and 3.7% year-over-year growth. The EPS forecast has slipped by $0.01 over the past 60 days.
2. Full-Year 2025 Projections
Full-year 2025 revenue is projected at $5.42 billion, down 18.2% from 2024, while EPS is forecast at $1.23, representing a 30.9% increase compared to the prior year. This divergence reflects a mix of lower overall volume and improved profitability per share.
3. Segment Performance Outlook
The Critical Illness Recovery segment is expected to deliver 2.1% revenue growth, a 2.8% rise in revenue per patient day, 3.8% higher admissions and a 67.3% occupancy rate. The Rehabilitation Hospital unit projects 11.1% revenue growth, 5.9% higher revenue per patient day, 10.4% more admissions and an 84.2% occupancy rate. Outpatient Rehabilitation EBITDA is forecast to jump 55.8%, with a 0.8% dip in revenue per visit offset by a 4.5% increase in visits. Total operating expenses are seen at $1.28 billion, while interest expense is projected to grow nearly 6%.